Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Tumor Microenvironment: Interactions and Therapy Publisher Pubmed



Najafi M1 ; Goradel NH2 ; Farhood B3 ; Salehi E4 ; Solhjoo S4 ; Toolee H4 ; Kharazinejad E5 ; Mortezaee K6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Radiology and Nuclear Medicine, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Radiology and Medical Physics, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, Iran
  4. 4. Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Anatomy, Abadan School of Medical Sciences, Abadan, Iran
  6. 6. Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

Source: Journal of Cellular Physiology Published:2019


Abstract

Tumor microenvironment (TME) is a host for a complex network of heterogeneous stromal cells with overlapping or opposing functions depending on the dominant signals within this milieu. Reciprocal paracrine interactions between cancer cells with cells within the tumor stroma often reshape the TME in favor of the promotion of tumor. These complex interactions require more sophisticated approaches for cancer therapy, and, therefore, advancing knowledge about dominant drivers of cancer within the TME is critical for designing therapeutic schemes. This review will provide knowledge about TME architecture, multiple signaling, and cross communications between cells within this milieu, and its targeting for immunotherapy of cancer. © 2018 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. Macrophage Polarity in Cancer: A Review, Journal of Cellular Biochemistry (2019)
2. Disruption of the Redox Balance With Either Oxidative or Anti-Oxidative Overloading As a Promising Target for Cancer Therapy, Journal of Cellular Biochemistry (2019)
3. Targeting Regulatory T Cells by Curcumin: A Potential for Cancer Immunotherapy, Pharmacological Research (2019)
4. Cyclooxygenase-2 in Cancer: A Review, Journal of Cellular Physiology (2019)
5. Adjuvant Chemotherapy With Melatonin for Targeting Human Cancers: A Review, Journal of Cellular Physiology (2019)
6. Cancer-Associated Fibroblasts (Cafs) and Tumor-Associated Macrophages (Tams); Where Do They Stand in Tumorigenesis and How They Can Change the Face of Cancer Therapy?, European Journal of Pharmacology (2022)
7. Nano-Immunotherapy: Overcoming Delivery Challenge of Immune Checkpoint Therapy, Journal of Nanobiotechnology (2023)
8. The Landscape of Exosomal Non-Coding Rnas in Breast Cancer Drug Resistance, Focusing on Underlying Molecular Mechanisms, Frontiers in Pharmacology (2023)
Experts (# of related papers)
View all Related Experts
Maryam Shabani Nashtaee (3)
Hamid Reza Mirzaei (2)
Other Related Docs
9. Pro-Tumorigenic Functions of Macrophages at the Primary, Invasive and Metastatic Tumor Site, Cancer Immunology# Immunotherapy (2020)
10. Epigenetic Strategies to Boost Car T Cell Therapy, Molecular Therapy (2021)
11. Targeting Axonal Degeneration and Demyelination Using Combination Administration of 17Β-Estradiol and Schwann Cells in the Rat Model of Spinal Cord Injury, Journal of Cellular Biochemistry (2018)
12. Car T Cell Therapy in Solid Tumors; With an Extensive Focus on Obstacles and Strategies to Overcome the Challenges, International Immunopharmacology (2021)
13. Regulatory T Cells in Breast Cancer As a Potent Anti-Cancer Therapeutic Target, International Immunopharmacology (2020)